CTRI/2024/02/062459尚未招募3 期
Randomised controlled clinical study to determine effect of Yashtimadhuka Taila Nasya in Akala Palitya (premature greying of hair) - Nil
CCRAS Ministry of AYUSH GOI0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Having signs and symptoms of Akala Palitya- Trace-Moderate Stage of Greying of hair on scale.
- •Fit for Nasya karma and willing to participate in the study.
- •Ready to obey instructions regarding restriction of hair dyeing for 2 months
- •Healthy volunteer
排除标准
- •known cases ofhair and scalp diseases like psoriasis, Eczema & Seborrhoic dermatitis.
- •Known cases of chronic systemic and metabolic diseases like DM, HIV, severe asthma, Cardiac diseases.
- •History of any treatment for hair loss and hair greying within the previous one month.
- •History of dyeing within the previous one month.
- •Premature aging disorders
- •Pregnant and lactating women
研究者
相似试验
已完成
不适用
Evaluation of the safety and initial performance of the REPAIR Bone Putty in the treatment of patients with tibia fracturesMusculoskeletal DiseasesOpen tibia fracturesPACTR201510001305535Carmell Therapeutics Corp.30
已完成
不适用
Randomized controlled clinical study to investigate effectiveness and safety of a Collagen Matrix 10808 for soft tissue volume augmentation after implant placement in single tooth gaps compared to autogenous connective tissue graftK08.1Loss of teeth due to accident, extraction or local periodontal diseaseDRKS00003586Geistlich Pharma AG20
尚未招募
2 期
Karanjadi Sarpi(Ghee) application in Diaper rashCTRI/2020/03/024336Sri Sri College of Ayurvedic Science and Research
尚未招募
2 期
Clinical study to see the effect of Rohitakadi powder and kutaj twak powder in the treatment of Raktarsha.CTRI/2024/03/064072Tilak Ayurved Mahavidyalaya
进行中（未招募）
不适用
Optimized TacrolimuS and MMF for HLA Antibodies (proteins that are sometimes produced by the immune system) after Renal TransplantatioRenal Transplant recipients with HLA antibodies, who are at increased risk of graft dysfunction and graft failureMedDRA version: 14.1Level: LLTClassification code 10050436Term: Prophylaxis against renal transplant rejectionSystem Organ Class: 100000004865EUCTR2012-004308-36-GBKings College London